Inventor
PATRICK JOSEPH ROBERTS
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes40%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds13%
C07KPeptides13%
PatentTitleYear
12,527,798Preservation of immune response during chemotherapy regimens202612,285,431Treatment of Rb-negative tumors using topoisomerase inhibitors in combination with cyclin dependent kinase 4/6 inhibitors202511,717,523Transient protection of normal cells during chemotherapy202311,654,148HSPC-sparing treatments for RB-positive abnormal cellular proliferation202311,529,352Preservation of immune response during chemotherapy regimens202211,446,295Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat Rb-positive tumors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to G1 THERAPEUTICS INC (5)· patent assignee history
2022–2026Based in US· patent location history
2025–2026Patents assigned to PHARMACOSMOS HOLDING AS (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| G1 THERAPEUTICS INC | 5 | 2022–2025 |
| PHARMACOSMOS HOLDING AS | 2 | 2025–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2026 |